Spindletop Health Acquisition Corp.
| IPO Proceeds, $M | $230.00M |
|---|---|
| IPO Date | Nov 4, 2021 |
| CEO | Evan S. Melrose, M.D., MBA |
| Left Lead | Barclays |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 15 + (3) or 15 + (2*3) |
| IPO Sector |
Healthcare
Healthcare services, healthcare information technology, insurance and related products, biotechnology, pharmaceuticals, medical devices, and diagnostics |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Dec 20, 2022 |
| Closing Date | Dec 20, 2022 |
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
No credit card required
Sign in for more on Spindletop Health Acquisition Corp.:
- Structure and cap table
- 8 directors & officers
- 12 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Evan S. Melrose, M.D., MBA | 51 | Chief Executive Officer, Chief Financial Officer and Director |
| James H. Henry, CPA | 63 | Chairman of the Board of Directors |
| Steve Whitlock, MBA | 59 | Secretary |
| JD Moore, MBA | 48 | Senior Vice President, Corporate Development |
| Kelly Huang, Ph.D. | 52 | Chief Operating Officer |
| Craig Cordola, MBA | 49 | Director |
| Todd Fruchterman, M.D., Ph.D. | 51 | Director |
| David Nash, M.D., MBA | 65 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
| Barclays | Joint BR | 13,000,000 | units |
| Stifel Nicolaus | Joint BR | 7,000,000 | |
| 20,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Filings
| Mar 19, 2021 | Initial S-1 |
| Aug 19, 2021 |
Amended S-1
Sign In to view filing content. |
| Oct 18, 2021 |
Amended S-1
Sign In to view filing content. |
| Nov 3, 2021 |
PR announcing pricing of $200mm IPO
Sign In to view filing content. |
| Nov 5, 2021 | 424B4 IPO Prospectus |
| Nov 8, 2021 |
PR announcing full over-allotment exercise
Sign In to view filing content. |
| Dec 21, 2021 |
8-K announcing separate trading of common stock and warrants
Sign In to view filing content. |
| Nov 21, 2022 |
PRE14A Preliminary Proxy for charter amendment meeting (liquidation)
Sign In to view filing content. |
| Dec 1, 2022 |
DEF14A Definitive Proxy for charter amendment meeting (liquidation)
Sign In to view filing content. |
| Dec 15, 2022 |
CA Corporate Action Alert with redemption rate and liquidation timeline
Sign In to view filing content. |
| Dec 23, 2022 |
CA Corporate Action Alert with redemption rate and liquidation timeline
Sign In to view filing content. |
| Dec 23, 2022 |
8-K with charter amendment meeting results
Sign In to view filing content. |